Hologic Inc (HOLX)

$

9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
.
9
8
7
6
5
4
3
2
1
0
0
$0.06 (-0.07%)Past Day

About

Hologic manufactures proprietary products for the healthcare needs of women. The company operates in five segments: diagnostics (60% of total sales, boosted by pandemic), breast health (14% of sales, suppressed by pandemic), surgical (11%), and skeletal health (1%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.

Key Insights

  • Share Price

    $81.13

  • Market Cap

    $18.93 Billion

  • Total Outstanding Shares

    233.38 Million Shares

  • Total Employees

    6,990

  • Dividend

    No dividend

  • IPO Date

    March 1, 1990

  • SIC Description

    X-ray Apparatus & Tubes & Related Irradiation Apparatus

  • Homepage

    http://www.hologic.com

Historical Stock Splits

If you bought 1 share of HOLX before December 1, 2005, you'd have 4 shares today.
Execution DateSplit Amount
April 3, 20082-for-1
December 1, 20052-for-1

Cash Flow Statement

June 30, 2023 to June 29, 2024
MetricValue
Net Cash Flow From Operating Activities, Continuing$1.18 Billion
Net Cash Flow From Investing Activities, Continuing$-241.30 Million
Net Cash Flow From Financing Activities, Continuing$-1.26 Billion
Net Cash Flow From Investing Activities$-241.30 Million
Net Cash Flow$-325.90 Million
Net Cash Flow From Financing Activities$-1.26 Billion
Net Cash Flow From Operating Activities$1.18 Billion
Exchange Gains/Losses$900000.00
Net Cash Flow, Continuing$-326.80 Million

Income Statement

June 30, 2023 to June 29, 2024
MetricValue
Interest Expense, Operating$118.30 Million
Other Operating Expenses$1.11 Billion
Cost Of Revenue$2.45 Billion
Net Income/Loss Available To Common Stockholders, Basic$701.50 Million
Income/Loss From Continuing Operations Before Tax$734.10 Million
Income Tax Expense/Benefit$87.60 Million
Benefits Costs and Expenses$3.20 Billion
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic$0.00
Diluted Average Shares$237.52 Million
Operating Expenses$1.39 Billion
Research and Development$278.40 Million
Revenues$3.99 Billion
Net Income/Loss$701.50 Million
Diluted Earnings Per Share$2.93
Income/Loss From Continuing Operations After Tax$701.50 Million
Net Income/Loss Attributable To Noncontrolling Interest$0.00
Basic Average Shares$235.83 Million
Gross Profit$2.17 Billion
Basic Earnings Per Share$2.95
Net Income/Loss Attributable To Parent$701.50 Million
Operating Income/Loss$785.10 Million
Preferred Stock Dividends And Other Adjustments$0.00
Income Tax Expense/Benefit, Deferred$-61.20 Million
Costs And Expenses$3.20 Billion

Balance Sheet

June 30, 2023 to June 29, 2024
MetricValue
Inventory$665.50 Million
Noncurrent Liabilities$2.94 Billion
Fixed Assets$528.80 Million
Long-term Debt$2.54 Billion
Other Current Assets$3.33 Billion
Equity Attributable To Parent$4.95 Billion
Other Current Liabilities$800.40 Million
Liabilities And Equity$8.89 Billion
Current Liabilities$1.00 Billion
Equity Attributable To Noncontrolling Interest$0.00
Other Non-current Liabilities$393.70 Million
Liabilities$3.94 Billion
Accounts Payable$202.00 Million
Current Assets$4.00 Billion
Intangible Assets$687.60 Million
Noncurrent Assets$4.89 Billion
Other Non-current Assets$3.68 Billion
Equity$4.95 Billion
Assets$8.89 Billion

Historical Dividends

Announcement DatePayment DateRecord DateAmountFrequency
No historical dividends
Boost your savings and earn 4.35% APY with a Marcus by Goldman Sachs savings account, a rate that's 8x the national averagewhen signing up with Financhle. No fees, no minimum deposits, backed by the financial expertise of Goldman Sachs. Terms apply.
News ArticlesAbout UsPrivacy Policy & Cookies Information

ⓒ2024 Financhle. All Rights Reserved.